BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8258234)

  • 1. Anti-Sm: its predictive value in systemic lupus erythematosus.
    Janwityanuchit S; Verasertniyom O; Vanichapuntu M; Vatanasuk M
    Clin Rheumatol; 1993 Sep; 12(3):350-3. PubMed ID: 8258234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of anti-Sm, anti-RNP, anti-Ro/SS-A, and anti-La/SS-B (extractable nuclear antigens) detected by enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus.
    Sánchez-Guerrero J; Lew RA; Fossel AH; Schur PH
    Arthritis Rheum; 1996 Jun; 39(6):1055-61. PubMed ID: 8651971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoblotting profiles in 55 systemic lupus erythematosus sera lacking precipitating antibodies to extractable nuclear antigens.
    Meyer O; Bourgeois P; Aeschlimann A; Haim T; Mery JP; Kahn MF
    Ann Rheum Dis; 1989 Jul; 48(7):594-9. PubMed ID: 2789021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-dsDNA and Sm autoantibodies in systemic lupus erythematosus.
    Martínez-Cordero E; Martínez-Miranda E; Negrete-García MC; Padilla A; Aguilar León DE
    Clin Rheumatol; 1992 Sep; 11(3):341-5. PubMed ID: 1458781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the clinical significance of anti-Sm antibodies in systemic lupus erythematosus? A comparison with anti-dsDNA antibodies and C3.
    Flechsig A; Rose T; Barkhudarova F; Strauss R; Klotsche J; Dähnrich C; Schlumberger W; Enghard P; Burmester GR; Hiepe F; Biesen R
    Clin Exp Rheumatol; 2017; 35(4):598-606. PubMed ID: 28281463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinuclear antibody profiles in relation to specific disease manifestations of systemic lupus erythematosus.
    Swaak AJ; Huysen V; Nossent JC; Smeenk RJ
    Clin Rheumatol; 1990 Mar; 9(1 Suppl 1):82-94. PubMed ID: 2203596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assays for Sm and RNP antibodies: pitfalls and technical considerations.
    Molden DP; Suzuki H; Nakamura RM
    Diagn Immunol; 1985; 3(1):24-8. PubMed ID: 3922661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinuclear antibodies in systemic lupus erythematosus.
    Fong KY; Boey ML; Howe HS; Feng PH
    Med J Malaysia; 1989 Jun; 44(2):151-5. PubMed ID: 2626124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiotypic independency of anti-dsDNA and anti-Sm antibodies in SLE sera.
    Kubota T; Dang H; Takei M; Miyasaka N; Kanai Y; Talal N
    Clin Exp Rheumatol; 1989; 7(5):572-3. PubMed ID: 2591135
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibodies to Sm in patients with systemic lupus erythematosus. Correlation of Sm antibody titers with disease activity and other laboratory parameters.
    Barada FA; Andrews BS; Davis JS; Taylor RP
    Arthritis Rheum; 1981 Oct; 24(10):1236-44. PubMed ID: 6975630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of antibodies to Sm (Smith) and RNP (ribonucleoprotein) in patients with rheumatic diseases.
    Tsay GJ; Su CB; Chen TY; Lin CS
    Taiwan Yi Xue Hui Za Zhi; 1984 May; 83(5):436-43. PubMed ID: 6332172
    [No Abstract]   [Full Text] [Related]  

  • 12. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
    Faria AC; Barcellos KS; Andrade LE
    J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of IgG anti-Sm antibodies in patients with systemic lupus erythematosus.
    Yasuma M; Takasaki Y; Matsumoto K; Kodama A; Hashimoto H; Hirose S
    J Rheumatol; 1990 Apr; 17(4):469-75. PubMed ID: 2348425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of anti-Sm antibodies in systemic lupus erythematosus.
    Beaufils M; Kouki F; Mignon F; Camus JP; Morel-Maroger L; Richet G
    Am J Med; 1983 Feb; 74(2):201-5. PubMed ID: 6600581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to Sm and RNP. Prognosticators of disease involvement.
    Munves EF; Schur PH
    Arthritis Rheum; 1983 Jul; 26(7):848-53. PubMed ID: 6603221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dsDNA binding to SmD-derived peptides on clinical accuracy in the diagnosis of systemic lupus erythematosus.
    Mahler M; Waka A; Hiepe F; Fritzler MJ
    Arthritis Res Ther; 2007; 9(4):R68. PubMed ID: 17640359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical expression of systemic lupus erythematosus with anti-U1-RNP and anti-Sm antibodies].
    López-Longo FJ; González Fernández CM; Rodríguez Mahou M; Grau Simó R; Monteagudo Sáez I; Meno García AC; Carreño Pérez L
    Rev Clin Esp; 1997 May; 197(5):329-35. PubMed ID: 9280966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic significance and diagnostic value of lupus autoantibodies.
    Tomer Y; Buskila D; Shoenfeld Y
    Int Arch Allergy Immunol; 1993; 100(4):293-306. PubMed ID: 8481649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?
    To CH; Petri M
    Arthritis Rheum; 2005 Dec; 52(12):4003-10. PubMed ID: 16320348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
    Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
    Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.